We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Lam Research
LRCX
$383B
| $331K | ﹤0.01% |
7,010
+10
| +0.1% | +$421 |
|
502
iShares MSCI Germany ETF
EWG
$1.67B
| $330K | ﹤0.01% |
10,387
+6
| +0.1% | +$180 |
|
|
CPTL
503
Global X Funds Global X Morningstar Capital Allocation Leaders ETF
CPTL
$120M
| $330K | ﹤0.01% |
+12,092
| New | +$314K |
|
504
Invitation Homes
INVH
$17.8B
| $324K | ﹤0.01% |
+10,909
| New | +$314K |
|
505
Medtronic
MDT
$114B
| $324K | ﹤0.01% |
2,766
+2,566
| +1,283% | +$282K |
|
506
Charter Communications
CHTR
$18.3B
| $318K | ﹤0.01% |
481
| – | – |
|
507
iShares S&P 500 Value ETF
IVE
$50B
| $311K | ﹤0.01% |
+2,429
| New | +$294K |
|
|
HEWG
508
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
| $308K | ﹤0.01% |
10,537
+1,641
| +18% | +$46.3K |
|
509
Workhorse Group
WKHS
$34.5M
| $305K | ﹤0.01% |
+5
| New | +$325K |
|
510
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $304K | ﹤0.01% |
4,935
+35
| +0.7% | +$2.17K |
|
511
QuickLogic
QUIK
$244M
| $303K | ﹤0.01% |
79,947
-53
| -0.1% | -$165 |
|
512
Warner Music
WMG
$13.8B
| $300K | ﹤0.01% |
7,897
-6,213
| -44% | -$189K |
|
513
iShares Russell 2000 Value ETF
IWN
$14.5B
| $299K | ﹤0.01% |
+2,269
| New | +$268K |
|
|
KYNB
514
Kyntra Bio
KYNB
$28.2M
| $297K | ﹤0.01% |
320
| – | – |
|
515
MetLife
MET
$61.7B
| $297K | ﹤0.01% |
6,326
+5,908
| +1,413% | +$256K |
|
|
CVAC
516
DELISTED
CureVac
CVAC
| $292K | ﹤0.01% |
3,602
+202
| +6% | +$15.5K |
|
517
Rollins
ROL
$17.9B
| $292K | ﹤0.01% |
7,474
+536
| +8% | +$20.8K |
|
518
Workday
WDAY
$45.5B
| $292K | ﹤0.01% |
1,219
-46
| -4% | -$10.3K |
|
|
P
519
Everpure Inc
P
$32.6B
| $283K | ﹤0.01% |
+12,517
| New | +$240K |
|
|
VXRT
520
DELISTED
Vaxart
VXRT
| $283K | ﹤0.01% |
49,562
-16,436
| -25% | -$105K |
|
521
Invesco Water Resources ETF
PHO
$2.09B
| $282K | ﹤0.01% |
6,071
+531
| +10% | +$23.2K |
|
522
Global X Cloud Computing ETF
CLOU
$271M
| $279K | ﹤0.01% |
+10,000
| New | +$257K |
|
523
Allstate
ALL
$68.2B
| $278K | ﹤0.01% |
2,529
-14
| -0.6% | -$1.38K |
|
524
iShares Core MSCI Total International Stock ETF
IXUS
$60.1B
| $276K | ﹤0.01% |
4,108
| – | – |
|
525
PACCAR
PCAR
$69.1B
| $275K | ﹤0.01% |
+4,781
| New | +$281K |
|
Similar funds
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.